Vital Biopharmaceutical Insights and Analytics

for Experts from Experts

Decision Resources is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.

Learn More

Search Reports


See which reports have been searched on the most.


In the Spotlight

Join us in San Francisco

Come join us for an exciting one-day seminar.
Walk away with expert insights on ACOs,
Exchanges and the impact of Healthcare Reform.

View the Agenda  |  Meet our expert speakers

Recent Reports [ view all ]

  • NSCLC (EGFR-Mutation-Positive; Previously Treated)

    Treatment decisions for non-small-cell lung cancer (NSCLC) patients are increasingly based on personalized... Read More

  • Acute Moderate to Severe Postoperative Pain: How Will U.S. Prescribers and Payers Determine the Success of Emerging Pain Therapies in the Hospital Setting?

    Although the postoperative pain market is sizeable in terms of both dollars and the potential patient pool, treatment... Read More

  • Alzheimer’s Disease (Mild to Moderate)

    With aging populations, the seven major pharmaceutical markets face an ever-expanding Alzheimer’s disease (AD) patient... Read More

Decision Resources Group brands include: